{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:27:27Z","timestamp":1793766447866,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clgc.2026.102637","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:42:45Z","timestamp":1785220965000},"page":"102637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications\u2014A Systematic Review"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-2952","authenticated-orcid":false,"given":"Charles Malisaba","family":"Posite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Wabinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Atwine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bienfait Mumbere","family":"Vahwere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Amini","family":"Mitamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoneste","family":"Hakizimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kiswezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Bassey","family":"Archibong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibe Michael","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2026.102637_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11255-023-03753-4","article-title":"Perspectives on prostate cancer: advances and pending challenges for a multidisciplinary oncological approach in South America","volume":"56","author":"Diaz","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.clgc.2026.102637_bib0002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7196\/SAMJ.2024.v114i4.1950","article-title":"Prostate cancer perspective: Africa versus the world","volume":"114","author":"Marais","year":"2024","journal-title":"South African Med J"},{"key":"10.1016\/j.clgc.2026.102637_bib0003","first-page":"24","article-title":"Epidemiology of prostate cancer in Africa: an in-depth review","volume":"4","author":"Nyiramana","year":"2024","journal-title":"Res Invent J Sci Exp Sci"},{"key":"10.1016\/j.clgc.2026.102637_bib0004","first-page":"1001","article-title":"Prostate cancer survival in sub \u2013 saharan Africa by age, stage at diagnosis, and human development index : a population-based registry study","volume":"32","author":"Seraphin","year":"2021","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clgc.2026.102637_bib0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12894-024-01683-6","article-title":"Prevalence of prostate cancer and its grade group stage at diagnosis in patients treated with prostatectomy in rural south western Uganda","volume":"24","author":"Mugarura","year":"2024","journal-title":"BMC Urol"},{"key":"10.1016\/j.clgc.2026.102637_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.911101","article-title":"Review of prostate cancer genomic studies in Africa","volume":"13","author":"Samtal","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.clgc.2026.102637_bib0007","first-page":"1","article-title":"Genetic risk of prostate cancer in Ugandan men","volume":"86","author":"Du","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.clgc.2026.102637_bib0008","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13104-020-05138-7","article-title":"Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions","volume":"13","author":"Ahmed","year":"2020","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.clgc.2026.102637_bib0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13000-024-01494-1","article-title":"A cross-sectional study of ERG expression and the relationship with clinicopathological features of prostate cancer in Southwestern Uganda","volume":"19","author":"Mitala","year":"2024","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.clgc.2026.102637_bib0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12301-020-00079-w","article-title":"Immunohistochemical expression of BRCA1 and BRCA2 in a cohort of Ugandan men with prostate cancer : an analytical cross \u2013 sectional study","volume":"26","author":"Amsi","year":"2020","journal-title":"African J Urol"},{"key":"10.1016\/j.clgc.2026.102637_bib0011","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41525-024-00446-4","article-title":"Germline sequence variation in cancer genes in Rwandan breast and prostate cancer cases","volume":"9","author":"Manirakiza","year":"2024","journal-title":"Genomic Med"},{"key":"10.1016\/j.clgc.2026.102637_bib0012","article-title":"The PRISMA 2020 statement : an updated guideline for reporting systematic reviews systematic reviews and meta-analyses","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2026.102637_bib0013","first-page":"481","article-title":"JBI manual for evidence synthesis","author":"Aromataris","year":"2024","journal-title":"JBI"},{"key":"10.1016\/j.clgc.2026.102637_bib0014","first-page":"269","article-title":"Immunohistochemical analysis of prostein in needle core biopsies of acinar and intraductal prostatic adenocarcinoma in Western Kenya population","volume":"6","author":"Swaya","year":"2022","journal-title":"J Cancer Sci Clin Ther"},{"key":"10.1016\/j.clgc.2026.102637_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/proc\/4406057","article-title":"Immunohistochemical detection of CD147 expression in adenocarcinoma of the prostate : a case-control study","author":"Suliman","year":"2024","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.clgc.2026.102637_bib0016","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12301-026-00556-8","article-title":"Clinicopathological features, management, and treatment outcome of prostate cancer in West and Central Africa : a systematic review","volume":"32","author":"Posite","year":"2026","journal-title":"African J Urol"},{"key":"10.1016\/j.clgc.2026.102637_bib0017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5534\/wjmh.210072","article-title":"Genomic profiling of prostate cancer : an updated review","volume":"40","author":"Hatano","year":"2022","journal-title":"World J Mens Health"},{"key":"10.1016\/j.clgc.2026.102637_bib0018","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1158\/1055-9965.EPI-15-1078","article-title":"Association of prostate cancer risk variants with TMPRSS2:ERG status: evidence for distinct molecular subtypes","volume":"25","author":"Penney","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clgc.2026.102637_bib0019","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01096-w","article-title":"Genome-wide interrogation of structural variation reveals novel African-specific prostate cancer oncogenic drivers","volume":"14","author":"Gong","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.clgc.2026.102637_bib0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/modpathol.2017.139","article-title":"Prostate cancer : diagnostic criteria and role of immunohistochemistry","volume":"31","author":"Magi-galluzzi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clgc.2026.102637_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02469-16","article-title":"Attenuated human parainfluenza virus type 1 expressing Ebola virus glycoprotein GP administered intranasally is immunogenic in African green monkeys","volume":"91","author":"Lingemann","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.clgc.2026.102637_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2023.1079037","article-title":"Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients","volume":"13","author":"Stevens","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.clgc.2026.102637_bib0023","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1200\/JCO.19.02768","article-title":"Molecular biomarkers in localized prostate cancer : ASCO Guideline abstract","volume":"38","author":"Eggener","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2026.102637_bib0024","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41588-020-00748-0","article-title":"Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction","volume":"53","author":"Conti","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.clgc.2026.102637_bib0025","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.2147\/CMAR.S382903","article-title":"Prostate cancer disparities and management in Southern Africa: insights into practices, norms and values","volume":"14","author":"Marima","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clgc.2026.102637_bib0026","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.urolonc.2024.07.014","article-title":"Barriers and facilitators of the application of precision medicine to the genitourinary cancer care pathway: perspective from a low-and middle-income country in sub-Saharan Africa","volume":"42","author":"Tolani","year":"2024","journal-title":"Urolofic Oncol Semin Orig Investig"},{"key":"10.1016\/j.clgc.2026.102637_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2024.1426558","article-title":"The future of collaborative precision oncology approaches in sub-Saharan Africa : learnings from around the globe","volume":"14","author":"Gueye","year":"2024","journal-title":"Front Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767326001370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:16:34Z","timestamp":1793765794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767326001370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1558767326001370"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102637","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunophenotyping and Molecular Patterns of Prostate Cancer in East Africa: Diagnostic and Prognostic Implications\u2014A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2026.102637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102637"}}